Evaluates the genotoxic effects of Salvia pratensis extracts and their silver nanoparticles in human lymphocytes, indicating potential risks and protective properties.
Biosynthesis of metal nanoparticles using plant extracts is considered an eco-friendly approach with promising biomedical applications; however, data on their safety, particularly genotoxicity, remain limited. This study evaluated the phenolic composition and genotoxic potential of aqueous extracts from the root (SPR) and aerial parts (SPA) of Salvia pratensis L. and their corresponding biogenic silver nanoparticles (SPR-AgNPs and SPA-AgNPs). Spectrophotometric methods were used to quantify total phenolic and flavonoid contents, and LC-MS analysis was employed to characterize the phenolic profiles. The genotoxic potential of the extracts and AgNPs was evaluated in human lymphocytes via the comet assay, with treatments applied at four concentrations ranging from 25 to 100 ?g/mL, either independently or in combination with hydrogen peroxide. Both extracts exhibited high phenolic content, with lower flavonoid levels in SPR. LC-MS analysis identified rosmarinic acid as the predominant compound in SPA and salvianolic acid K in SPR. Both extracts and AgNPs increased DNA damage in lymphocytes. In contrast, only the SPA extract lowered H?O?- induced DNA damage, demonstrating a pronounced protective effect. These findings indicate potential genotoxic risks associated with S. pratensis extracts and their AgNPs, while also highlighting selective protective properties depending on the plant part used.
No takes yet. Share an insight, caveat, or question.
Jakovljević et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: